{"count": 7, "results": [{"_id": "37133558", "pmid": 37133558, "pmcid": "PMC10172247", "title": "The comparative effectiveness of metformin and risperidone in a rat model of valproic acid-induced autism, Potential role for enhanced autophagy", "journal": "Psychopharmacology (Berl)", "authors": ["Atia AA", "Ashour RH", "Zaki MM", "Rahman KM", "Ramadan NM"], "date": "2023-06-01T00:00:00Z", "doi": "10.1007/s00213-023-06371-1", "meta_date_publication": "2023 Jun", "meta_volume": "240", "meta_issue": "6", "meta_pages": "1313-1332", "score": 50260.94, "text_hl": "The effectiveness of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on alleviation of @DISEASE_Autism_Spectrum_Disorder @DISEASE_MESH:D000067877 @@@ASD@@@-like @<m>DISEASE_Attention_Deficit_and_Disruptive_Behavior_Disorders</m> @DISEASE_MESH:D019958 @@@behavioral deficits@@@ in adolescent @SPECIES_10116 @@@rats@@@ exposed prenatally to @CHEMICAL_Valproic_Acid @CHEMICAL_MESH:D014635 @@@valproic acid@@@ (@CHEMICAL_Valproic_Acid @CHEMICAL_MESH:D014635 @@@VPA@@@) was compared to that of @CHEMICAL_Risperidone @CHEMICAL_MESH:D018967 @@@risperidone@@@. ", "citations": {"NLM": "Atia AA, Ashour RH, Zaki MM, Rahman KM, Ramadan NM. The comparative effectiveness of metformin and risperidone in a rat model of valproic acid-induced autism, Potential role for enhanced autophagy Psychopharmacology (Berl). 2023 Jun;240(6):1313-1332. PMID: 37133558", "BibTeX": "@article{37133558, title={The comparative effectiveness of metformin and risperidone in a rat model of valproic acid-induced autism, Potential role for enhanced autophagy}, author={Atia AA and Ashour RH and Zaki MM and Rahman KM and Ramadan NM}, journal={Psychopharmacology (Berl)}, volume={240}, number={6}, pages={1313-1332}}"}}, {"_id": "32048246", "pmid": 32048246, "title": "Metformin accelerates myelin recovery and ameliorates behavioral deficits in the animal model of multiple sclerosis via adjustment of AMPK/Nrf2/mTOR signaling and maintenance of endogenous oligodendrogenesis during brain self-repairing period.", "journal": "Pharmacol Rep", "authors": ["Sanadgol N", "Barati M", "Houshmand F", "Hassani S", "Clarner T", "Shahlaei M", "Golab F"], "date": "2020-06-01T00:00:00Z", "doi": "10.1007/s43440-019-00019-8", "meta_date_publication": "2020 Jun", "meta_volume": "72", "meta_issue": "3", "meta_pages": "641-658", "score": 50253.496, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ accelerates myelin recovery and ameliorates @<m>DISEASE_Attention_Deficit_and_Disruptive_Behavior_Disorders</m> @DISEASE_MESH:D019958 @@@behavioral deficits@@@ in the animal model of @DISEASE_Multiple_Sclerosis @DISEASE_MESH:D009103 @@@multiple sclerosis@@@ via adjustment of AMPK/@GENE_NFE2L2 @GENE_18024 @@@Nrf2@@@/@GENE_MTOR @GENE_56717 @@@mTOR@@@ signaling and maintenance of endogenous oligodendrogenesis during brain self-repairing period.", "citations": {"NLM": "Sanadgol N, Barati M, Houshmand F, Hassani S, Clarner T, Shahlaei M, Golab F. Metformin accelerates myelin recovery and ameliorates behavioral deficits in the animal model of multiple sclerosis via adjustment of AMPK/Nrf2/mTOR signaling and maintenance of endogenous oligodendrogenesis during brain self-repairing period. Pharmacol Rep. 2020 Jun;72(3):641-658. PMID: 32048246", "BibTeX": "@article{32048246, title={Metformin accelerates myelin recovery and ameliorates behavioral deficits in the animal model of multiple sclerosis via adjustment of AMPK/Nrf2/mTOR signaling and maintenance of endogenous oligodendrogenesis during brain self-repairing period.}, author={Sanadgol N and Barati M and Houshmand F and Hassani S and Clarner T and Shahlaei M and Golab F}, journal={Pharmacol Rep}, volume={72}, number={3}, pages={641-658}}"}}, {"_id": "32538851", "pmid": 32538851, "title": "Dendrobium nobile Lindl. Alkaloids Ameliorate Cognitive Dysfunction in Senescence Accelerated SAMP8 Mice by Decreasing Amyloid-beta Aggregation and Enhancing Autophagy Activity.", "journal": "J Alzheimers Dis", "authors": ["Lv LL", "Liu B", "Liu J", "Li LS", "Jin F", "Xu YY", "Wu Q", "Liu J", "Shi JS"], "date": "2020-01-01T00:00:00Z", "doi": "10.3233/JAD-200308", "meta_date_publication": "2020", "meta_volume": "76", "meta_issue": "2", "meta_pages": "657-669", "score": 50242.7, "text_hl": "Age-matched SAMR1 @SPECIES_10090 @@@mice@@@ were used as controls. DNLA and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatments ameliorated @<m>DISEASE_Attention_Deficit_and_Disruptive_Behavior_Disorders</m> @DISEASE_MESH:D019958 @@@behavioral deficits@@@ of 12-month-old @CELLLINE_CVCL:K252 @@@SAMP8@@@ @SPECIES_10090 @@@mice@@@, as determined by Rotarod, Y-maze, and Open-field tests. ", "citations": {"NLM": "Lv LL, Liu B, Liu J, Li LS, Jin F, Xu YY, Wu Q, Liu J, Shi JS. Dendrobium nobile Lindl. Alkaloids Ameliorate Cognitive Dysfunction in Senescence Accelerated SAMP8 Mice by Decreasing Amyloid-beta Aggregation and Enhancing Autophagy Activity. J Alzheimers Dis. 2020;76(2):657-669. PMID: 32538851", "BibTeX": "@article{32538851, title={Dendrobium nobile Lindl. Alkaloids Ameliorate Cognitive Dysfunction in Senescence Accelerated SAMP8 Mice by Decreasing Amyloid-beta Aggregation and Enhancing Autophagy Activity.}, author={Lv LL and Liu B and Liu J and Li LS and Jin F and Xu YY and Wu Q and Liu J and Shi JS}, journal={J Alzheimers Dis}, volume={76}, number={2}, pages={657-669}}"}}, {"_id": "35373418", "pmid": 35373418, "title": "Developmental arsenic exposure impairs cognition, directly targets DNMT3A, and reduces DNA methylation.", "journal": "EMBO Rep", "authors": ["Yan N", "Li Y", "Xing Y", "Wu J", "Li J", "Liang Y", "Tang Y", "Wang Z", "Song H", "Wang H", "Xiao S", "Lu M"], "date": "2022-06-07T00:00:00Z", "doi": "10.15252/embr.202154147", "meta_date_publication": "2022 Jun 7", "meta_volume": "23", "meta_issue": "6", "meta_pages": "e54147", "score": 50234.844, "text_hl": "@GENE_DNMT3A @GENE_13435 @@@DNMT3A@@@ degradation leads to genome-wide DNA hypomethylation in @SPECIES_10090 @@@mouse@@@ embryonic fibroblasts but not in non-embryonic cell lines. Treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, a first-line antidiabetic agent reported to increase DNA methylation, ameliorates the @<m>DISEASE_Attention_Deficit_and_Disruptive_Behavior_Disorders</m> @DISEASE_MESH:D019958 @@@behavioral deficits@@@ and normalizes the aberrant expression of cognition-related genes and DNA methylation in the hippocampus of @CHEMICAL_Arsenic @CHEMICAL_MESH:D001151 @@@arsenic@@@-exposed offspring. ", "citations": {"NLM": "Yan N, Li Y, Xing Y, Wu J, Li J, Liang Y, Tang Y, Wang Z, Song H, Wang H, Xiao S, Lu M. Developmental arsenic exposure impairs cognition, directly targets DNMT3A, and reduces DNA methylation. EMBO Rep. 2022 Jun 7;23(6):e54147. PMID: 35373418", "BibTeX": "@article{35373418, title={Developmental arsenic exposure impairs cognition, directly targets DNMT3A, and reduces DNA methylation.}, author={Yan N and Li Y and Xing Y and Wu J and Li J and Liang Y and Tang Y and Wang Z and Song H and Wang H and Xiao S and Lu M}, journal={EMBO Rep}, volume={23}, number={6}, pages={e54147}}"}}, {"_id": "28035478", "pmid": 28035478, "title": "Metformin Attenuates Cognitive Impairments in Hypoxia-Ischemia Neonatal Rats via Improving Remyelination.", "journal": "Cell Mol Neurobiol", "authors": ["Qi B", "Hu L", "Zhu L", "Shang L", "Sheng L", "Wang X", "Liu N", "Wen N", "Yu X", "Wang Q", "Yang Y"], "date": "2017-10-01T00:00:00Z", "doi": "10.1007/s10571-016-0459-8", "meta_date_publication": "2017 Oct", "meta_volume": "37", "meta_issue": "7", "meta_pages": "1269-1278", "score": 50049.758, "text_hl": "These data indicate that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ is beneficial for the amelioration of @DISEASE_Hypoxia_Ischemia_Brain @DISEASE_MESH:D020925 @@@H/I@@@-induced myelination and @<m>DISEASE_Attention_Deficit_and_Disruptive_Behavior_Disorders</m> @DISEASE_MESH:D019958 @@@behavior deficits@@@.", "citations": {"NLM": "Qi B, Hu L, Zhu L, Shang L, Sheng L, Wang X, Liu N, Wen N, Yu X, Wang Q, Yang Y. Metformin Attenuates Cognitive Impairments in Hypoxia-Ischemia Neonatal Rats via Improving Remyelination. Cell Mol Neurobiol. 2017 Oct;37(7):1269-1278. PMID: 28035478", "BibTeX": "@article{28035478, title={Metformin Attenuates Cognitive Impairments in Hypoxia-Ischemia Neonatal Rats via Improving Remyelination.}, author={Qi B and Hu L and Zhu L and Shang L and Sheng L and Wang X and Liu N and Wen N and Yu X and Wang Q and Yang Y}, journal={Cell Mol Neurobiol}, volume={37}, number={7}, pages={1269-1278}}"}}, {"_id": "30555309", "pmid": 30555309, "pmcid": "PMC6281763", "title": "Metformin Administration During Early Postnatal Life Rescues Autistic-Like Behaviors in the BTBR T+ Itpr3tf/J Mouse Model of Autism", "journal": "Front Behav Neurosci", "authors": ["Wang L", "Cai Y", "Fan X"], "date": "2018-11-29T00:00:00Z", "doi": "10.3389/fnbeh.2018.00290", "meta_date_publication": "2018", "meta_volume": "12", "meta_issue": "", "meta_pages": "290", "score": 50046.97, "text_hl": "Our findings suggest that early @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment may have beneficial effects on ameliorating @<m>DISEASE_Attention_Deficit_and_Disruptive_Behavior_Disorders</m> @DISEASE_MESH:D019958 @@@behavioral deficits@@@ in @DISEASE_Autism_Spectrum_Disorder @DISEASE_MESH:D000067877 @@@ASD@@@.", "citations": {"NLM": "Wang L, Cai Y, Fan X. Metformin Administration During Early Postnatal Life Rescues Autistic-Like Behaviors in the BTBR T+ Itpr3tf/J Mouse Model of Autism Front Behav Neurosci. 2018;12():290. PMID: 30555309", "BibTeX": "@article{30555309, title={Metformin Administration During Early Postnatal Life Rescues Autistic-Like Behaviors in the BTBR T+ Itpr3tf/J Mouse Model of Autism}, author={Wang L and Cai Y and Fan X}, journal={Front Behav Neurosci}, volume={12}, pages={290}}"}}, {"_id": "24649970", "pmid": 24649970, "title": "Chronic metformin treatment improves post-stroke angiogenesis and recovery after experimental stroke.", "journal": "Eur J Neurosci", "authors": ["Venna VR", "Li J", "Hammond MD", "Mancini NS", "McCullough LD"], "date": "2014-06-01T00:00:00Z", "doi": "10.1111/ejn.12556", "meta_date_publication": "2014 Jun", "meta_volume": "39", "meta_issue": "12", "meta_pages": "2129-38", "score": 50044.95, "text_hl": "Importantly even if @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment was initiated 24 h after injury it enhanced recovery and significantly improved @DISEASE_Stroke @DISEASE_MESH:D020521 @@@stroke@@@-induced @<m>DISEASE_Attention_Deficit_and_Disruptive_Behavior_Disorders</m> @DISEASE_MESH:D019958 @@@behavioral deficits@@@. ", "citations": {"NLM": "Venna VR, Li J, Hammond MD, Mancini NS, McCullough LD. Chronic metformin treatment improves post-stroke angiogenesis and recovery after experimental stroke. Eur J Neurosci. 2014 Jun;39(12):2129-38. PMID: 24649970", "BibTeX": "@article{24649970, title={Chronic metformin treatment improves post-stroke angiogenesis and recovery after experimental stroke.}, author={Venna VR and Li J and Hammond MD and Mancini NS and McCullough LD}, journal={Eur J Neurosci}, volume={39}, number={12}, pages={2129-38}}"}}]}